AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2013
Nov 15, 2013
30718_dirs_2013-11-15_ad50e94c-c579-4423-80b4-d897fb16d6c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-11-13
Reporting Person: STEER RANDOLPH C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-13 | Common Stock | M | 5000 | $66.59 | Acquired | 6000 | Direct |
| 2013-11-13 | Common Stock | M | 5000 | $65.47 | Acquired | 11000 | Direct |
| 2013-11-13 | Common Stock | M | 5000 | $63.03 | Acquired | 16000 | Direct |
| 2013-11-13 | Common Stock | S | 15000 | $86.2 | Disposed | 1000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-13 | Stock Option | $66.59 | M | 5000 | Disposed | 2017-10-24 | Common Stock (5000) | Direct |
| 2013-11-13 | Stock Option | $65.47 | M | 5000 | Disposed | 2018-10-22 | Common Stock (5000) | Direct |
| 2013-11-13 | Stock Option | $63.03 | M | 5000 | Disposed | 2019-10-28 | Common Stock (5000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $87.39 | 2023-10-30 | Common Stock (4000) | 4000 | Direct |
| Stock Option | $66.9 | 2022-10-24 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $70.35 | 2021-10-26 | Common Stock (5000) | 5000 | Direct |
| Stock Option | $61.46 | 2020-10-27 | Common Stock (5000) | 5000 | Direct |
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4